MALAT1 and neoplasm: Notably, g#5 reduced the growth of AMO-BZB-luc xenografts (Fig. 1e and Fig. S4a); on-target activity of g#5 in vivo was confirmed by reduced MALAT1 levels in resected tumor samples after g#5 treatment (Supplementary Fig. S4b).